BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $508,697 | +22.6% | 13,479 | +48.1% | 0.17% | +26.3% |
| Q2 2023 | $414,778 | +12.4% | 9,104 | +0.1% | 0.13% | +8.1% |
| Q1 2023 | $369,055 | +16.2% | 9,099 | +46.1% | 0.12% | +11.8% |
| Q4 2022 | $317,492 | -6.1% | 6,229 | -0.7% | 0.11% | -9.1% |
| Q3 2022 | $338,000 | -16.1% | 6,273 | 0.0% | 0.12% | -9.7% |
| Q2 2022 | $403,000 | -17.4% | 6,273 | -0.4% | 0.13% | -5.0% |
| Q1 2022 | $488,000 | -10.1% | 6,298 | -0.4% | 0.14% | -1.4% |
| Q4 2021 | $543,000 | +2.5% | 6,323 | -4.0% | 0.14% | -11.2% |
| Q3 2021 | $530,000 | -2.6% | 6,588 | -2.4% | 0.16% | -1.2% |
| Q2 2021 | $544,000 | -4.6% | 6,753 | -0.1% | 0.16% | -8.4% |
| Q1 2021 | $570,000 | -20.1% | 6,758 | -23.9% | 0.18% | -23.6% |
| Q4 2020 | $713,000 | -0.1% | 8,886 | 0.0% | 0.23% | -8.6% |
| Q3 2020 | $714,000 | -6.7% | 8,886 | 0.0% | 0.26% | -14.7% |
| Q2 2020 | $765,000 | +5.8% | 8,886 | -0.2% | 0.30% | -3.2% |
| Q1 2020 | $723,000 | -16.5% | 8,906 | -14.1% | 0.31% | -6.6% |
| Q4 2019 | $866,000 | +104.7% | 10,366 | +114.4% | 0.33% | +27.8% |
| Q3 2019 | $423,000 | +6.0% | 4,836 | -0.7% | 0.26% | +6.6% |
| Q2 2019 | $399,000 | -4.5% | 4,871 | -5.2% | 0.24% | -7.3% |
| Q1 2019 | $418,000 | +23.7% | 5,136 | 0.0% | 0.26% | +10.1% |
| Q4 2018 | $338,000 | -21.2% | 5,136 | -7.6% | 0.24% | -3.3% |
| Q3 2018 | $429,000 | +3.4% | 5,561 | -1.2% | 0.25% | -2.8% |
| Q2 2018 | $415,000 | +13.4% | 5,626 | 0.0% | 0.25% | +11.9% |
| Q1 2018 | $366,000 | -1.3% | 5,626 | -2.0% | 0.23% | -0.4% |
| Q4 2017 | $371,000 | +0.8% | 5,741 | -2.1% | 0.23% | -4.6% |
| Q3 2017 | $368,000 | -1.3% | 5,866 | -4.9% | 0.24% | -4.4% |
| Q2 2017 | $373,000 | +16.6% | 6,166 | 0.0% | 0.25% | +13.2% |
| Q1 2017 | $320,000 | +14.3% | 6,166 | -2.5% | 0.22% | +12.8% |
| Q4 2016 | $280,000 | -7.0% | 6,326 | 0.0% | 0.20% | -9.7% |
| Q3 2016 | $301,000 | +2.7% | 6,326 | -2.3% | 0.22% | -2.7% |
| Q2 2016 | $293,000 | +8.1% | 6,476 | -1.7% | 0.22% | +8.3% |
| Q1 2016 | $271,000 | +29.0% | 6,590 | +19.5% | 0.20% | +28.9% |
| Q4 2015 | $210,000 | – | 5,515 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |